Navigation Links
Ankle-Arm Blood Pressure Test Predicts Heart Disease Risk
Date:7/8/2008

Could improve current assessments, report says

TUESDAY, July 8 (HealthDay News) -- A seldom-used test that measures blood pressure in the ankle and the arm can help improve assessment of the risk of heart disease, stroke and other cardiovascular problems, an international research group reports.

It has a distinct advantage in that it is extremely easy to perform and doesn't require expensive, sophisticated equipment, Gerry Fowkes, a professor of epidemiology at the University of Edinburgh, Scotland, said of the ankle brachial index (ABI). The device is the subject of a report in the July 9 issue of the Journal of the American Medical Association. The index is the ratio between the blood pressure measurements in the ankle and the arm.

The ABI should be used to supplement rather than replace standard measures of cardiovascular risk such as cholesterol, blood pressure, obesity and physical activity, Fowkes said.

"It has been shown that using these common risk factors, prediction is not as good as it might be," he said. "That is why we and others have been looking for other factors to improve prediction."

The meta-analysis used data from 16 studies around the world, including 24,955 men and 23,339 women who were followed after an initial ABI measurement. Over the next 10 years, 4.4 percent of men with a normal ABI died, compared to 18.7 percent of men with an abnormally low ABI. Death rates for women were 12.6 percent for those with a low ABI, 4.1 percent for those with a normal ABI.

A lower ABI was associated with approximately a doubled risk of death from any cause, cardiovascular death, and a major coronary event over the 10 years, the report said. Including the ABI in current risk factor assessments would mean reclassification of cardiovascular risk and change of the measures taken to prevent cardiovascular events for 19 percent of men and 36 percent of women, the researchers estimated.'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Fish oil and red yeast rice studied for lowering blood cholesterol
2. The Foundation for Accelerated Vascular Research Grants $150,000 Wylie Scholar Award for Blood Vessel Research
3. Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure
4. Taking Control: Future Therapies for a Host of Serious Diseases May Be Found in Womens Menstrual Blood
5. FDA Grants AMDL Clearance to Market the AMDL-ELISA DR-70(R) (FDP) Blood Test for Monitoring Colorectal Cancer
6. Working Hard When Tired Raises Blood Pressure
7. Blood vessel inhibitor shows promise against metastatic thyroid cancer
8. Hibernation-on-demand drug significantly improves survival after extreme blood loss
9. Release of Kowalski Book on Attaining Healthy Blood Pressure Coincides with Website Launch, New Endurance Products SR L-Arginine and Grape Seed Extract
10. Scientists find how neural activity spurs blood flow in the brain
11. Umbilical cord blood cell transplants may help ALS patients

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ankle-Arm Blood Pressure Test Predicts Heart Disease Risk
Ankle-Arm Blood Pressure Test Predicts Heart Disease Risk
(Date:11/9/2009)... chains are often blamed for the increasing rates ....au however finds that 80% of people think that pa... (PRWEB) November 9, 2009 -- If ... behind Australia’s obesity epidemic, think ...standers. A recent survey commissioned for Fitnes...
(Date:11/9/2009)...o be Offered in April 2010, Provides First Respond... Cambridge, MA (Vocus) November 9, 2009 -- Whe...HR) first inspected a suspected mass grave at Das...eed a team of experts to help interpret the scene....key first step in securing evidence of a human rig...
(Date:11/9/2009)...ncer Network (NCCN) has posted a draft white paper...for near-term comparative effectiveness clinical e...introduces the NCCN Comparative Therapeutic Index(... the risk-versus-benefit of different treatment op...idelines in Oncology(TM). The paper will be posted...
(Date:11/9/2009)...swire/ -- Health Connect Partners, Inc., ( www.hl...ugural Hospital O.R. and Surgery Center Conference...e Hotel in Nashville, Tenn. ,, Health Connect P...ing room directors and managers from some of the l.... Some of the confirmed providers include HCA, Bon...
(Date:11/9/2009)...-- Highlighting a commitment to providing long-ter...ent and digital display technology options, LG Ele...nd Hospital Grade LCD HDTVs this week at the Assoc...nual meeting and exposition (booth #1760). ,, O...ew(TM)" Long-Term Care LCD HDTVs bring a sense of ...
Breaking Medicine News(10 mins):Health News:Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5
...ransmitter dopamine has long been known to play a ... mutations in a protein called parkin// cause a fo... scientists, reporting in the Jan. 31 issue of The... researchers show for the first time that a mutate...
...ly aggressive treatment with disease-modifying ant...reventing joint damage and avoiding the// fate of ...idely prescribed and generally safe methotrexate, ...sease, which is marked by chronic inflammation of ...
...ium picolinate published in the current edition of...t chromium picolinate is //effective in improving ...eople with type 2 diabetes. The review, whic...zed efficacy after combining results from all type...
...gainst exposing their unborn baby to a 3D ultrasou...such a move is fraught with risks. This// advice h... growing popularity of three dimensional ultrasoun... in 2005, so that they could monitor their baby’s ...
... simple, safe and cost-effective dipstick for the ...ay its low cost, sensitivity and ease of// use mak...gesh Tripathi and colleagues at the India-based De...rated into a dipstick that shows a brown dot if a ...
...ff for a week of sun, snow, and après-ski. And whi...onsider the dangers of skin// cancer? It is ...e than 69,000 new cases reported every year. The i...ferent nationalities behave while having fun in th...
Other Medicine News:Health News:UCLA Find Yields Further Insight into Causes of Parkinson’s Diseas 2Health News:Rheumatoid Arthritis: Early Aggressive Treatment Needed 2Health News:Chromium Picolinate Effective for Diabetes Care 2Health News:Chromium Picolinate Effective for Diabetes Care 3Health News:The Psychology of Skin Cancer 2
(Date:11/9/2009)...ONOUGH, Ga., Nov. 9 Hi...ounced the formation of a joint venture that will ...ive range of surface replacement systems that are ...as replacements for surfaces that are technologica...Hill-Rom, a global leader in patient support syste...
(Date:11/9/2009)...Newswire-Asia-FirstCall/ -- American Oriental,Bioe..."AOBO"), a pharmaceutical,company dedicated to imp... and,commercialization of a broad range of prescri... announced that it plans to release third quarter ...9, after the market closes. , The Company...
(Date:11/9/2009)...wire/ -- MISSION Skincare®, the innovative sk...ams, soccer professional Mia Hamm, and other world...le Skincare Destinations" in the beauty aisle of m...ountry beginning this week. Stocked with innovativ...nd CVS/pharmacy have set out to establish the late...
Breaking Medicine Technology:Hill-Rom and Encompass Group Form Joint Venture 2Hill-Rom and Encompass Group Form Joint Venture 3Hill-Rom and Encompass Group Form Joint Venture 4Hill-Rom and Encompass Group Form Joint Venture 5Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National 'Active Lifestyle Skincare Destinations' 2Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National 'Active Lifestyle Skincare Destinations' 3Web based innovation improves eases agricultural terrace design 10030 1Web based innovation improves eases agricultural terrace design 10030 2Abortion Opponents Launch Massive Grassroots Mobilization in 212 Cities 58020 1Abortion Opponents Launch Massive Grassroots Mobilization in 212 Cities 58020 2ScienceFirst Staff Expansion 58015 1
...led to Reach Statistical ...Y HILLS, Mass., Dec. 5 /PRNewswire-,FirstCall/ -- ...nd its,wholly- owned subsidiary, Unither Pharmaceu...eir two pivotal trials of OvaRex(R) MAb for the,tr...alysis demonstrates,that the studies failed to rea...
...r Patients, ROCKVILLE, Md., Dec. 4 EntreMed, Inc...l company developing,therapeutics for the treatmen...nced that it has commenced a multi-center Phase 2 ...d pancreatic cancer. The primary objectives,of thi...y of,orally-administered MKC-1 in unresectable or ...
Other Medicine Technology:Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 2Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 3Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint 4EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 2EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 3EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer 4
SYNCHRON LX®20 PRO
BN100
Bilitec 2000 Recorder
...y, pathology specimen imaging is now advancing tow...tion, analysis, interpretation and telepathology. ...gous to the change that occurred in radiology, and...departments and imaging clinics through the introd...
Medicine Products: